About Neoolife
Neoolife is a Healthcare company based in Pittsburgh (United States) founded in 2020 by Antonio D Amore. Developer of a device for cardiovascular disease treatment. Its chief executive, as recorded, is David Kokot. Neoolife offers products and services including OneValve Tric and DCD Tissue Engineering. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Surgical Devices. Its legal entity is Neoolife, Inc. Its competitors include Sofregen, Cerapedics and Healionics; 3 of its 3 listed competitors have raised funding.
Company details
Neoolife was founded in 2020 in Pittsburgh, United States, and operates in the medical device sector focused on cardiovascular health. Tissue-engineered Biomimetic Heart Valves (BMHV) and Biomimetic Cardiovascular Patches (BMCP) are developed to support tissue regeneration. These products are designed for both percutaneous and surgical applications in treating cardiovascular diseases. Leadership includes co-founder and CTO Antonio D Amore, along with CEO David Kokot.
- Headquarters Pittsburgh, United States
- Founders Antonio D Amore
- SectorsHealthcare
- Email••••••••
- Website neoolife.com
- Social LinkedIn
- Legal Name Neoolife, Inc.
- Latest Funding Round$553.84K (USD), Grant
May 2023
- Investors
Products & Services of Neoolife
Neoolife offers a comprehensive portfolio of products and services, including OneValve Tric and DCD Tissue Engineering.
Biomimetic polymeric valve for tricuspid replacement and thrombosis resistance.
Method for creating non-animal-derived heart valves.
Funding Insights of Neoolife
- Total Rounds 1
- Last Round Grant — $553,838
- First Round $553,838
(May 2023)
- Investors Count 1
All 1 funding rounds of Neoolife with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $553,838 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Neoolife
Neoolife has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Neoolife
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neoolife
2 people are tracked at Neoolife (2 in leadership).
| Name | Role | Group |
|---|---|---|
Antonio D Amore | Co-Founder & CTO | Leadership |
David Kokot | CEO | Leadership |
Complete people profiles for Neoolife
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neoolife
2 dated milestones of Neoolife across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Neoolife is founded.
- Funding First funding round of $554K.
Competitors of Neoolife
Neoolife has 3 listed competitors in our database, 3 of them funded. They include Sofregen, Cerapedics and Healionics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sofregen.com | 2014 | Medford, United States | $17.8M | 8 | Silk-derived biomaterials are developed for soft tissue repair in surgery. | |
| cerapedics.com | 2006 | Westminster, United States | $88.46M | 3 | Osteobiologic products are developed using synthetic peptide technology. | |
| healionics.com | 2007 | Seattle, United States | $26.58M | Innovative biomaterials are developed for dialysis access solutions. |
Detailed competitors of Neoolife
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Organ-on-Chip & Regenerative Solutions
3 companies that operate in the same segment as Neoolife (Organ-on-Chip & Regenerative Solutions) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Synthetic adhesives for bone and dental repair are developed. | 2014 | Lowell, Massachusetts, United States | USD 24.42 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neoolife
Neoolife was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Neoolife is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
David Kokot is the CEO of Neoolife, as recorded in our data.
Neoolife was founded in 2020 in Pittsburgh, United States, and operates in the medical device sector focused on cardiovascular health. Tissue-engineered Biomimetic Heart Valves (BMHV) and Biomimetic Cardiovascular Patches (BMCP) are developed to support tissue regeneration. These products are designed for both percutaneous and surgical applications in treating cardiovascular diseases. Leadership includes co-founder and CTO Antonio D Amore, along with CEO David Kokot.
Neoolife's top competitors include Cerapedics, Sofregen and Healionics.
Neoolife offers OneValve Tric and DCD Tissue Engineering.
Neoolife has 1 investor. Key investors include HHS.
Neoolife operates through Neoolife, Inc..